metricas
covid
Buscar en
Enfermedades Infecciosas y Microbiología Clínica
Toda la web
Inicio Enfermedades Infecciosas y Microbiología Clínica Infecciones producidas por los virus de la gripe aviar A (H5N1) en las poblacion...
Journal Information
Vol. 22. Issue 7.
Pages 412-418 (August 2004)
Share
Share
Download PDF
More article options
Vol. 22. Issue 7.
Pages 412-418 (August 2004)
Full text access
Infecciones producidas por los virus de la gripe aviar A (H5N1) en las poblaciones de aves del sudeste asiático y en la especie humana
Avian influenza A (H5N1) infectious in both birds and humans in South-Eastern Asian countries
Visits
13307
Pilar Pérez-Breña1
Corresponding author
pperez@isciii.es

Correspondencia: Dra. P. Pérez-Breña. Servicio de Virología. Centro Nacional de Microbiología. Instituto de Salud Carlos III. Ctra. de Majadahonda-Pozuelo, km 2. 28220 Majadahonda. Madrid. España.
, Inmaculada Casas
Servicio de Virología. Centro Nacional de Microbiología. Instituto de Salud Carlos III. Majadahonda. Madrid. España
This item has received
Article information

La gripe aviar afecta a la mayoría de las aves y produce epidemias en granjas. La enfermedad fatal se denomina “gripe aviar altamente patogénica” y se relaciona con el virus Influenza A de los subtipos H5 y H7. El reservorio natural son las aves migratorias que infectan accidentalmente a las aves domésticas. En 1997, en Hong Kong, 18 personas se infectaron por virus A(H5N1) y seis de ellas fallecieron. Al final de 2003 y principio de 2004, el mismo subtipo infectó numerosas granjas en países del sureste asiático. Este virus fue transmitido a 34 personas en contacto directo con aves infectadas y 23 personas fallecieron. La intensa investigación en curso sobre virus H5N1 se centra principalmente en su alta tasa de evolución, virulencia, probabilidad de producción de recombinantes con otros virus Influenza, variantes H5N1 capaces de infectar al ser humano o aproximaciones al desarrollo de vacunas eficaces.

Palabras clave:
Gripe aviar
Influenza A(H5N1)
Factores de virulencia
Evolución de virus Influenza

Avian influenza affects most types of birds and occurs in epidemics on poultry farms. The fatal disease is named “highly pathogenic avian influenza” and is caused by influenza A virus subtypes H5 and H7. The natural reservoir is the migratory waterfowl that occasionally infects domestic poultry. In 1997 in Hong Kong, 18 persons were infected and 6 of them died. At the end of 2003 and the beginning of 2004, avian influenza H5N1 infected numerous farms in several South-Eastern Asian countries. The virus was transmitted to humans in close contact with infected birds. A total of 34 persons were infected and 23 of them died. There is currently a considerable concern about the H5N1 avian influenza that has infected humans: the high virulence, evolution rate, the possibility of recombination with other influenza viruses, how H5N1 variants that infect humans or different approaches to the development of influenza vaccines.

Key words:
Avian Influenza
Influenza A(H5N1)
Virulence factors
Influenza evolution
Full text is only aviable in PDF
Bibliografía
[1.]
A. Robert, Lamb, M. Robert, K. Krug.
Orthomyxoviridae: The viruses and their replication, fields virology. Cap. 46. 3rd ed.
[2.]
Y. Kawaoka, C.W. Naeve, R.G. Webster.
Is virulence of H5N2 influenza viruses in chickens associated with loss of carbohydrate from the hemagglutinin?.
Virology, 139 (1984), pp. 303-316
[3.]
J. Banks, E.S. Speidely, E. Moore, L. Plowright, A. Piccirillo, I. Capua, et al.
Changes in the haemagglutinin and the neuraminidase genes prior to the emergence of highly pathogenic H7N1 avian influenza viruses in Italy.
Arch Virol, 146 (2001), pp. 963-973
[4.]
N.R. Donelan, C.F. Basler, A. García-Sastre.
A recombinant influenza A virus expressing an RNA-binding-defective NS1 protein induces high levels of beta interferon and is attenuated in mice.
J Virol, 77 (2003), pp. 13257-13266
[5.]
T. Saito, T. Horimoto, Y. Kawaoka, D.A. Senne, R.G. Webster.
Emergence of a potentially pathogenic H5N2 influenza virus in chickens.
Virology, 201 (1994), pp. 277-284
[6.]
V.S. Hinshaw, R.G. Webster, B. Turner.
The perpetuation of orthomyxoviruses and paramyxoviruses in Canadian waterfowl.
Can J Microbiol, 26 (1980), pp. 622-629
[7.]
K. Iwatsuki-Horimoto, R. Kanazawa, S. Sugii, Y. Kawaoka, T. Horimoto.
The index influenza A virus subtype H5N1 isolated from a human in 1997 differs in its receptor-binding properties from a virulent avian influenza virus.
J Gen Virol, 85 (2004), pp. 1001-1005
[8.]
J.S. Peiris, W.C. Yu, C.W. Leung, C.Y. Cheung, W.F. Ng, J.M. Nicholls, et al.
Re-emergence of fatal human influenza A subtype H5N1 disease.
Lancet, 21 (2004), pp. 617-619
[9.]
K.M. Sturm-Ramirez, T. Ellis, B. Bousfield, L. Bissett, K. Dyrting, J.E. Rehg, et al.
Reemerging H5N1 Influenza Viruses in Hong Kong in 2002 Are Highly Pathogenic to Ducks.
J Virol, 1 (2004), pp. 4892-4901
[10.]
T.H. Tran, T.L. Nguyen, T.D. Nguyen, T.S. Luong, P.M. Pham, V.C. Nguyen, et al.
World Health Organization International Avian Influenza Investigative Team. Avian influenza A (H5N1) in 10 patients in Vietnam.
N Engl J Med, 18 (2004), pp. 1179-1188
[11.]
M. Liu, J.M. Wood, T. Ellis, S. Krauss, P. Seiler, C. Johnson, et al.
Preparation of a standardized, efficacious agricultural H5N3 vaccine by reverse genetics.
Virology, 314 (2003), pp. 580-590
[12.]
R.J. Webby, D.R. Pérez, J.S. Coleman, Y. Guan, J.H. Knight, E.A. Govorkova, et al.
Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines.
Lancet, 363 (2004), pp. 1099-1103
[13.]
C.L. Qiao, K.Z. Yu, Y.P. Jiang, Y.Q. Jia, G.B. Tian, M. Liu, et al.
Protection of chickens against highly lethal H5N1 and H7N1 avian influenza viruses with a recombinant fowlpox virus co-expressing H5 haemagglutinin and N1 neuraminidase genes.
Avian Dis, 47 (2003), pp. 1127-1130
[14.]
European Commission. Commission suspends EU poultry imports from Thailand after avian influenza outbreak. Press release IP/04/95,23 January 2004. (http://europa.eu.int/rapid/start/cgi/guesten.ksh?p_action.gettxt=gt&doc=IP/04/95|0|RAPID≶=en&display=).
Copyright © 2004. Elsevier España, S.L.. Todos los derechos reservados
Download PDF
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos